|
|
 |
|
Viewing report
|
|
|
|
Radiometer Medical ApS - Product Pipeline Analysis
GlobalData, Nov 2011, Pages: 21
Radiometer Medical ApS - Product Pipeline Analysis
Summary
Radiometer Medical ApS (Radiometer) is a privately-held medical device company, which is engaged in the development, manufacture and distribution of advanced acute care testing solutions within blood gas testing, transcutaneous monitoring and testing of cardiac, coagulation and infection markers. The company operates through five companies, namely, Radiometer Medical ApS, Denmark; SenDx Medical, Inc., the US; Radiometer Basel AG, Switzerland; Innotrac Diagnostics Oy, Finland and Radiometer Stargard, Poland. Its products are distributed and sold in more than 100 countries throughout the world. Radiometer has companies in 15 countries, which are responsible for the sales and distribution of our products and services globally. Radiometer is a subsidiary of Danaher Corporation. The company is headquartered at Bronshoj, Denmark.
The company’s products and solutions include blood gas testing analyzers, transcutaneous monitors and sensors, immunoassay analyzers to measures cardiac, coagulation, infection and pregnancy markers and IT systems. Radiometer’s blood gas analyzers include automated features, which simplify workflow, minimize errors and enhance turnaround time. Used with its safePICO samplers and RADIANCE DMS, the ABL80 FLEX and ABL800 FLEX analyzers provide speed and accuracy for the lab and the point of care. The company’s Transcutaneous (TCM) monitors and sensors offer transcutaneous pO2 and pCO2 information easily, continuously and non-invasively to intensive care, neonatal intensive care, respiratory, sleep medicine and wound care areas. Its AQT90 FLEX analyzer measures cardiac, coagulation, infection and pregnancy markers from a single sample. Its IT solutions is used for point-of-care testing and ensure regulatory compliance. This also includes RADIANCE systems ans QA portal. In addition to products, Radiometer offers services such as quality assurance support (QA), training and technical support.
This report is a source for data, analysis and actionable intelligence on the Radiometer Medical ApS portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
|
|
|
|
